Investors Asset Management of Georgia’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-202	Closed	-$21K	–	397
2022 Q3	$21K	Hold	202	–	–	0.01%	396
2022 Q2	$20K	Buy	+202	New	+$20K	0.01%	339